At 49, Hyderabad-based neurologist Dr. Sudhir Kumar was overweight, battling ankylosing spondylitis, and struggling with poor lifestyle hab...

Zydus Lifesciences gets USFDA nod for Celecoxib capsules. The approval includes various strengths of the drug. It will manufacture the drug...

A study of South Indian populations reveals a nearly 60% inbreeding rate due to endogamy, linked to increased genetic disorder risks. Resea...

Adalimumab BS for subcutaneous injection is indicated for immune-related diseases such as rheumatoid arthritis, psoriasis vulgaris, ankylos...

Zydus Lifesciences has gained the US Food and Drug Administration's (FDA) approval to produce and market its Indomethacin suppositories. Th...

Enzene or its parent Alkem which is commercialising the drug didn't announce the price, but said it would be competitively priced.

The company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200...

Keeping bedroom warm, letting go of stress and relaxing before falling asleep can work wonders.

Initial symptoms may not appear alarming, but they can be serious.

Mumbai based Lupin pharma and Japan's Nichi-Iko have tied up for the distribution, promotion and sale of Lupin’s recently-filed biosimilar ...

For Infliximab, Reliance Life Sciences had completed process development, manufacturing, clinical trials in India and obtained marketing ap...

The company's product will be available as pre-filled syringe of 40 mg, Torrent Pharmaceuticals said in a statement.

The Department of Industrial Policy and Promotion is expected to soon take the draft IPR policy to the Cabinet for approval.

A team of doctors at a city hospital here have performed minimal access spine surgery on an 82-year -old 'Ankylosing Spondylitis' patient.

Infimab has been introduced in the Indian market through a licensing partnership with Epirus Biopharmaceuticals, Ranbaxy said in a statemen...

The company has also received tentative approvals for its product in strengths of 100 mg, 200 mg and 400 mg from the FDA.

Drug major Cipla said it has launched biosimilar of Etanercept under the brand name 'Etacept' used for treatment of rheumatic disorders in ...